 |
|
 |
 |

Home > Company Index > Drugs > Drug Manufacturers - Major > Endo Pharmaceuticals Holdings, Inc.
 |
Endo Pharmaceuticals Holdings, Inc. |
 |
 |
 |
PROFILE |
 |
Endo Pharmaceuticals Holdings wants to put an end to your pain. The company, formed when Endo Pharmaceuticals bought Algos Pharmaceutical, specializes in products for pain management and for the treatment of coughs and colds. Endo markets both branded and generic drugs; brand products include Percocet tablets (which contain acetaminophin), Percodan tablets (which contain aspirin), and Numorphan, a suppository. Products in development include MorphiDex, an enhanced opioid analgesic. Originally a family-run drug business, Endo was operated as a DuPont-Merck joint venture until 1997; investment firm Kelso & Company financed a management buyout and now owns about 80% of Endo.
COMPETITION |
 |
Bayer AG (BAYZY)
Pain Therapeutics, Inc. (PTIE)
Perrigo Company (PRGO)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 197.40
1-Yr. Sales Growth: 42.5%
Employees: 140
Revenue per employee: $1,410,000.00
KEY PEOPLE |
 |
Carol A. Ammon
CEO
Jeffrey R. Black
CFO
CONTACT INFO |
 |
223 Wilmington West Chester Pike
Chadds Ford, PA 19317
US
Phone: 610-558-9800
Fax: 610-558-7699
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |